… is decreased in patients with nonvalvular atrial fibrillation (AF… CCS was abandoned in clinical
practice. The role of NOACs … the NOAC (apixaban) against VKA in a factorial comparison.[…

… observational studies comparing effectiveness and safety of … an important therapeutic
alternative to vitamin K antagonists (… are likely to reflect routine clinical practice in Germany and …

… treatment for stroke prevention in patients with AF has been based on the administration of a
vitamin K antagonist (… clinical practice and validated by the expert panel, with a routine visit …

… to dabigatran during routine clinical practice were recruited and … patient satisfaction in
patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin …

… comparable if not superior efficacy and safety over vitamin K antagonists (VKA) [6]. In daily
… private practices and hospitals in the administrative district of Dresden (Saxony), Germany. …

… events in patients with non-valvular atrial fibrillation (9). Considering the efficacy and safety
of … off-label for anticoagulation therapy in patients with LVT in clinical practice. To date, most …

… of anticoagulation alone in AF, ie, non-vitamin K oral … ASA to be a costeffective alternative
to treatment with VKA+ASA… efficacy and safety of the use of non-vitamin-K antagonist …

… One ongoing trial in Germany is comparing apixaban to VKA [42]. … Vitamin K antagonists
for stroke prevention in hemodialysis patients with atrial fibrillation: a systematic review and meta…

… and poor compliance with practice guidelines seem common in clinical practice [5]… comparison
results, while comparison between either dosage of rivaroxaban and vitamin K antagonist …

… for clinical decision-making , the cost-effectiveness of apixaban (API) versus rivaroxaban (…
the cost of DOACs (70–80%), it is limited to patients with non-valvular atrial fibrillation and …